Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5923
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mueller, Jannis | - |
dc.contributor.author | Sharmin, Sifat | - |
dc.contributor.author | Lorscheider, Johannes | - |
dc.contributor.author | Ozakbas, Serkan | - |
dc.contributor.author | Karabudak, Rana | - |
dc.contributor.author | Horakova, Dana | - |
dc.contributor.author | Kalincik, Tomas | - |
dc.date.accessioned | 2025-02-25T19:31:36Z | - |
dc.date.available | 2025-02-25T19:31:36Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 1352-4585 | - |
dc.identifier.issn | 1477-0970 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.14365/5923 | - |
dc.description | Turkoglu, Recai/0000-0001-9724-851X; Roos, Izanne/0000-0003-0371-3666 | en_US |
dc.description.sponsorship | Swiss National Science Foundation [P500PM_214230] | en_US |
dc.description.sponsorship | This work was supported by the Swiss National Science Foundation (Grant No. P500PM_214230). The authors received personal fees, and/or travel support, and/or speaker fees, and/or research grants, and/or served as advisory board members of Alexion (AG, FP, MJS, DM, VVP, SR, TD, AAA, TK), Almirall (FP, MD, VVP, TCT, JLSM, DP, OY), Bayer (DH, BWG, CB, RA, SE, OS, BT, DS, PMC, NG, ND, SF, LK), Bayer Schering (MT, DS, BT, ND, SF), Bayer Schering Pharma (WMC), BMS (CMG, BVW, CG), Biogen (JL, DH, BWG, CB, RA, FP, GI, SE, MT, AG, VT, AGM, WMC, FGM, MPA, PG, KB, OS, AVDW, YB, BY, SJK, MB, NJ, JLC, MF, VVP, JP, MJS, DM, MD, SH, CMG, BT, DS, RG, CRT, CS, EC, MH, BVW, RA, RM, COG, KDG, GL, JO, JG, PMC, OG, EAM, JLSM, PL, SF, JK, OY, TK, IR), Biogen Idec (DH, SE), BioCSL (AGM), Bristol (FP, AG, VT, SE, TCT), Bristol Myers Squibb (AG, VT, MJS, DM, LK), Celgene (BWG, BVW, JO), Celgene-BMS (COG), CSL Australia (BT), EMD Serono (BWG, PG), Genentech (BWG), Genzyme (AGM, WMC, FGM, KB, OS, CMG, PG, RM, SF, TD, CG), GSK (RA), Horizon (AG), Innate Immunotherapeutics (AGM), Janssen (BWG, FP, SE, MJS, DM, BVW, CG, LK), Merck (DH, CB, RA, FP, GI, SE, MT, AG, VT, AGM, WMC, FGM, MPA, PG, KB, OS, AVDW, YB, BY, SJK, MB, NJ, JLC, MF, VVP, JP, MJS, DM, MD, SH, DS, RG, CRT, CS, EC, MH, BVW, RA, RM, COG, KDG, GL, JO, NG, TAH, AAA, SMB, DP, ND, PL, SF, JK, TD), Merck Healthcare KGaA (Darmstadt, Germany) (VVP), Merck Serono (AG, MD), MSBase Registry (SS), Novartis (JL, DH, BWG, CB, RA, FP, GI, SE, MT, AG, VT, AGM, WMC, FGM, MPA, PG, KB, OS, AVDW, YB, BY, MB, NJ, JLC, MF, VVP, JP, MJS, DM, MD, SH, CMG, BT, DS, MPC, RG, CRT, CS, EC, MH, BVW, RA, RM, COG, KDG, GL, JO, JG, PMC, OG, EAM, JLSM, TK, IR), Pendopharm (PG), Quanterix (JK), Roche (JL, DH, CB, RA, FP, GI, SE, MT, AG, VT, AGM, WMC, FGM, MPA, PG, KB, MD, SH, CMG, BT, RG, CRT, CS, EC, MH, BVW, RM, COG, KDG, GL, JO, JG, OG, EAM, PL, SF, JK, TD, CG, LK, IR), Sanofi (GI, CB, RA, AG, YB, RG, CRT, CS, EC, MH, AAA), Sanofi Aventis (CB, MT, CS), Sanofi-Genzyme (DH, BWG, RA, VT, AGM, WMC, FGM, KB, MD, SH, RG, CRT, CS, EC, MH, BVW, KDG, GL, JO, EAM, TCT, NG, TAH, AAA, MiS), Sandoz (YB, CRT), Stata DX (JK), Teva (JL, DH, CB, RA, FP, GI, SE, MT, AGM, WMC, KB, RA, JP, MJS, DM, TCT, TAH, COG, AAA, NG, Ricardo Fernandez Bolanos), Teva Neurosciences (FGM), Viatris (COG). JM. SO, VS, ME, CB, AP, SAS, RT, AA, AS, OG, SN, CZ, EC, MS, MZ, NS, MDG, KGP, LF, MER, SV, EL, DK, TAH, JIR, SB, MLS, JACB reported no competing interests. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Ltd | en_US |
dc.relation.ispartof | 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- SEP 18-20, 2024 -- Copenhagen, DENMARK | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | A Standardised Definition of Progression Independent of Relapse Activity in Multiple Sclerosis | en_US |
dc.type | Conference Object | en_US |
dc.department | İzmir Ekonomi Üniversitesi | en_US |
dc.authorid | 0000-0001-9724-851X | - |
dc.authorid | 0000-0003-0371-3666 | - |
dc.authorwosid | Soysal, Aysun/Aax-7696-2021 | - |
dc.authorwosid | Foschi, Matteo/Abr-7231-2022 | - |
dc.authorwosid | Terzi̇, Murat/Aaa-1284-2021 | - |
dc.authorwosid | Lorscheider, Johannes/Aau-2509-2020 | - |
dc.authorwosid | Patti, Francesco/C-3300-2011 | - |
dc.authorwosid | Boz, Cavit/Aar-2268-2020 | - |
dc.authorwosid | Roos, Izanne/Abo-3767-2022 | - |
dc.identifier.volume | 30 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 442 | en_US |
dc.identifier.endpage | 445 | en_US |
dc.identifier.wos | WOS:001324906901146 | - |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopusquality | Q1 | - |
dc.identifier.wosquality | N/A | - |
dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | - |
item.openairetype | Conference Object | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
crisitem.author.dept | 09.02. Internal Sciences | - |
Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
Sorry the service is unavailable at the moment. Please try again later.
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.